Africa faces a staggering 67% mortality-to-incidence ratio from cancer, according to data from the World Health Organization’s International Agency for Research on Cancer (IARC). While 82% of African countries now have national cancer-control plans—up from 50% in 2010, according to the WHO—systemic bottlenecks in early detection, referral pathways, and financial access continue to restrict survival rates across the continent.
The Gap Between Policy and Clinical Delivery
National commitments to cancer control have expanded substantially over the past decade, yet the translation of policy into everyday healthcare delivery remains uneven. According to the WHO, 73% of countries maintain formal cancer guidelines, but only 52% of those nations report that guidelines are implemented in at least half of their health facilities. Furthermore, just 28% of countries include comprehensive cancer care in publicly financed health-benefit packages.
“The primary gap is no longer a gap in knowledge,” the WHO stated in written responses to Nature Africa, noting that the challenge lies squarely in connecting detection, diagnosis, and treatment so patients do not drop out of care.
This structural disconnect is sharply visible in patient outcomes. New estimates of five-year breast cancer survival put the median survival rate in the WHO African Region at 39.1%, compared with 84% in Europe and 88.5% in the Americas. More than half of countries in the African Region record five-year survival rates below 50%.
Geographic Disparities and Financial Toxicity
For millions of patients, the physical journey to care is as formidable as the disease itself. According to Bahija Gouimi, president and founder of the AMAL Association for leukaemia patients in Morocco, individuals frequently travel between 100 and 600 kilometres to reach specialist oncology centers. Because cancer requires prolonged diagnostic testing and repeated treatment cycles, these journeys span months or years.
Even when medical procedures are publicly covered, transport, accommodation, and lost income generate profound financial toxicity. “Some patients delay appointments, skip follow-up visits, interrupt treatment, or even abandon care because they simply cannot afford the cost of accessing it,” Gouimi explains. To counter this, organizations like AMAL operate support facilities such as Dar Al Amal to house patients travelling long distances.
Similar challenges define the public health landscape in South Africa. Approximately 86% of South Africans rely on the public healthcare system for oncology, according to Salomé Meyer, CEO of the advocacy group Cancer Alliance. Meyer notes that delays frequently occur within the public health infrastructure itself during diagnosis and referral phases. Because provincial governments carry primary responsibility for funding, the lack of dedicated provincial budgets, trained personnel, and diagnostic tools creates severe bottlenecks for rural communities.
Egypt’s Patient-Navigation Model
To combat late-stage diagnoses, Egypt has restructured its approach by integrating screening directly with treatment pathways. Launched in 2019, the Presidential Initiative for Women’s Health utilizes primary-care facilities across all 27 governorates to provide awareness and clinical examinations.
According to Hesham Elghazaly, professor of clinical oncology at Ain Shams University and head of the initiative, the program has reached more than 23 million women. Crucially, the system functions as a patient-navigation framework rather than a standalone screening campaign. Women with abnormal findings are actively tracked through diagnostic imaging, biopsies, and specialist care.
Elghazaly reports a substantial shift toward early detection: roughly 58% of breast cancers were previously diagnosed at stages III or IV, whereas 19.5% are now identified at those advanced stages, with 80.5% caught at stages 0 through II.
Workforce Deficits and the Regional Cancer Burden
Across the wider continent, deficits in the oncology workforce severely restrict care delivery along the entire clinical continuum. Dr. Miriam Mutebi, president-elect of the African Organization for Research and Training in Cancer (AORTIC), highlights that oncology care varies wildly even within individual countries, juxtaposing state-of-the-art facilities against deeply under-resourced regional clinics.
“Many patients in Africa are diagnosed with advanced cancers and do not complete their care,” Mutebi notes, pointing to out-of-pocket costs, poor referral networks, and socio-cultural barriers such as stigma and fatalism. In sub-Saharan Africa, general hospitals frequently lack basic reagents for diagnostic tests, forcing patients to travel hours only to find facilities unequipped to process biopsies.
BVGH’s African Access Initiative (AAI) and other capacity-building frameworks are attempting to address these shortages through targeted training for pathologists and nurses, virtual tumor boards, and efforts to close the “cancer data gap” caused by the historical underrepresentation of African patient tumor genetics in global clinical trials.
Keep reading